540701 Stock Overview
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Dishman Carbogen Amcis Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹219.30 |
| 52 Week High | ₹282.95 |
| 52 Week Low | ₹113.25 |
| Beta | 1.2 |
| 1 Month Change | 1.22% |
| 3 Month Change | 16.03% |
| 1 Year Change | 58.91% |
| 3 Year Change | 41.35% |
| 5 Year Change | -1.79% |
| Change since IPO | -37.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540701 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | -9.5% | -0.4% | -2.1% |
| 1Y | 58.9% | 14.9% | 45.3% |
Return vs Industry: 540701 exceeded the Indian Life Sciences industry which returned 14.9% over the past year.
Return vs Market: 540701 exceeded the Indian Market which returned 45.3% over the past year.
Price Volatility
| 540701 volatility | |
|---|---|
| 540701 Average Weekly Movement | 8.9% |
| Life Sciences Industry Average Movement | 6.1% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 540701 has not had significant price volatility in the past 3 months.
Volatility Over Time: 540701's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 1,295 | Arpit Vyas | imdcal.com |
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitizers, antiseptics, vitamin D analogues, cholesterol, lanolin-related products, disinfectant formulations, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients.
Dishman Carbogen Amcis Limited Fundamentals Summary
| 540701 fundamental statistics | |
|---|---|
| Market cap | ₹35.67b |
| Earnings (TTM) | -₹1.54b |
| Revenue (TTM) | ₹25.80b |
1.3x
P/S Ratio-22.3x
P/E RatioIs 540701 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540701 income statement (TTM) | |
|---|---|
| Revenue | ₹25.80b |
| Cost of Revenue | ₹7.32b |
| Gross Profit | ₹18.47b |
| Other Expenses | ₹20.02b |
| Earnings | -₹1.54b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | -9.84 |
| Gross Margin | 71.62% |
| Net Profit Margin | -5.98% |
| Debt/Equity Ratio | 40.0% |
How did 540701 perform over the long term?
See historical performance and comparison